The American Independent has previously reported on the growing corporatization of the incipient medical marijuana industry at a time when medical marijuana dispensaries scrabble to hold on to their businesses in the face of a multi-pronged federal crackdown. But there are signs afoot that it just may become More…
On Monday, The New York Times ran a damning story detailing how the nation’s drug makers are hiking their prices ahead of the reform laws winding their way through Congress. The very next day, some powerful House Democrats called for a closer look, asking the Government Accountability Office More…
Sens. Byron Dorgan (D-N.D.) and Olympia Snowe (R-Maine) just shot out a statement reacting to the recent deal cut between the White House and the pharmaceutical industry to trim prescription drug costs for millions of Medicare patients. Here’s a hint: They’re not terribly impressed.
“Even with PhRMA’s offer to More…
rss